105 related articles for article (PubMed ID: 3181417)
1. Effect of chemical modification at C1 of the glucosamine backbone of lipid A-subunit analog GLA-27 on manifestation of immunopharmacological activity.
Kumazawa Y; Takimoto H; Yamamoto A; Homma JY; Ogawa Y; Kiso M; Hasegawa A
FEBS Lett; 1988 Oct; 239(1):117-20. PubMed ID: 3181417
[TBL] [Abstract][Full Text] [Related]
2. Importance of fatty acid substituents of chemically synthesized lipid A-subunit analogs in the expression of immunopharmacological activity.
Kumazawa Y; Nakatsuka M; Takimoto H; Furuya T; Nagumo T; Yamamoto A; Homma Y; Inada K; Yoshida M; Kiso M
Infect Immun; 1988 Jan; 56(1):149-55. PubMed ID: 3257202
[TBL] [Abstract][Full Text] [Related]
3. Structural requirements for inducing in vitro B lymphocyte activation by chemically synthesized derivatives related to the nonreducing D-glucosamine subunit of lipid A.
Kumazawa Y; Matsuura M; Maruyama T; Homma JY; Kiso M; Hasegawa A
Eur J Immunol; 1986 Sep; 16(9):1099-103. PubMed ID: 3489621
[TBL] [Abstract][Full Text] [Related]
4. Immunopharmacological activities of 2-keto-3-deoxyoctonic acid-(alpha 2----6)-linked 4-O-phosphono-D-glucosamine derivatives carrying N- and 3-O-acyl substituents.
Kumazawa Y; Matsuura M; Homma JY; Furuya T; Takimoto H; Inagaki K; Nagumo T; Kiso M; Hasegawa A
Infect Immun; 1989 Jun; 57(6):1845-8. PubMed ID: 2785963
[TBL] [Abstract][Full Text] [Related]
5. Effect of stereospecificity of chemically synthesized lipid A-subunit analogues GLA-27 and GLA-40 on the expression of immunopharmacological activities.
Kumazawa Y; Ikeda S; Takimoto H; Nishimura C; Nakatsuka M; Homma JY; Yamamoto A; Kiso M; Hasegawa A
Eur J Immunol; 1987 May; 17(5):663-7. PubMed ID: 3495442
[TBL] [Abstract][Full Text] [Related]
6. Non-specific protective activity of synthetic lipid A-subunit analogs against microbial infections is influenced by their 2-N- and 3-O-linked acyl substituents in the D-glucosamine backbone.
Ikeda S; Matsuura M; Nakatsuka M; Homma JY; Kiso M; Hasegawa A; Nishimura C
J Clin Lab Immunol; 1990 Aug; 32(4):177-81. PubMed ID: 1966934
[TBL] [Abstract][Full Text] [Related]
7. Effects of backbone structures and stereospecificities of lipid A-subunit analogues on their biological activities.
Matsuura M; Kojima Y; Homma JY; Kumazawa Y; Yamamoto A; Kiso M; Hasegawa A
J Biochem; 1986 May; 99(5):1377-84. PubMed ID: 3486867
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of nonspecific resistance to microbial infections of synthetic lipid A-subunit analogues of GLA-27 modified at the C1 position of the glucosamine backbone.
Nakatsuka M; Ikeda S; Kumazawa Y; Matsuura M; Nishimura C; Homma JY; Kiso M; Hasegawa A
Int J Immunopharmacol; 1990; 12(6):599-603. PubMed ID: 1703131
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of nonspecific resistance to bacterial infections and tumor regressions by treatment with synthetic lipid A-subunit analogs. Critical role of N- and 3-O-linked acyl groups in 4-O-phosphono-D-glucosamine derivatives.
Nakatsuka M; Kumazawa Y; Matsuura M; Homma JY; Kiso M; Hasegawa A
Int J Immunopharmacol; 1989; 11(4):349-58. PubMed ID: 2777430
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of nonspecific resistance to viral infection by chemically synthesized lipid A-subunit analogs with different backbone structures and acyl groups.
Ikeda S; Kumazawa Y; Nishimura C; Nakatsuka M; Homma JY; Kiso M; Hasegawa A
Antiviral Res; 1988 Dec; 10(4-5):167-78. PubMed ID: 2465734
[TBL] [Abstract][Full Text] [Related]
11. Immunopharmacological activities of chemically synthesized lipid A-subunit analogue GLA-27 combined with muramyl dipeptide via spacers of different carbon chain length.
Ikeda S; Kumazawa Y; Sai K; Nishimura C; Nakatsuka M; Homma JY; Yamamoto A; Kiso M; Hasegawa A
Int J Immunopharmacol; 1988; 10(4):339-46. PubMed ID: 2459075
[TBL] [Abstract][Full Text] [Related]
12. Antiviral and immunomodulating activities of chemically synthesized lipid A-subunit analogues GLA-27 and GLA-60.
Ikeda S; Nishimura C; Nakatsuka M; Homma JY; Kiso M; Hasegawa A
Antiviral Res; 1988; 9(1-2):37-46. PubMed ID: 3389769
[TBL] [Abstract][Full Text] [Related]
13. Lipid A and related compounds. XXVI. Syntheses of biologically active penta-O-acetyl-N-glycoloylneuraminyl- and penta-O-acetyl-3-deoxy-D-galacto-2- nonulopyranosonic acid-(alpha 2----6)-D-glucosamine-4-phosphate analogs of lipid A.
Ikeda K; Kawai K; Achiwa K
Chem Pharm Bull (Tokyo); 1991 May; 39(5):1305-9. PubMed ID: 1914005
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of the optically active 4-O-phosphono-D-glucosamine derivatives related to the nonreducing-sugar subunit of bacterial lipid A.
Kiso M; Tanaka S; Fujita M; Fujishima Y; Ogawa Y; Ishida H; Hasegawa A
Carbohydr Res; 1987 Apr; 162(1):127-40. PubMed ID: 3594476
[TBL] [Abstract][Full Text] [Related]
15. Lipid A and related compounds. XXIX. Synthesis of biologically active N-acylated L-asparagine-containing D-glucosamine derivatives structurally related to lipid A.
Suhara Y; Arakawa M; Ikeda K; Achiwa K
Chem Pharm Bull (Tokyo); 1994 Dec; 42(12):2526-31. PubMed ID: 7697768
[TBL] [Abstract][Full Text] [Related]
16. Neuraminic acid and related compounds. I. Syntheses of biologically active 4',7',8',9'-tetra-O-acetyl-sialyl- and sialyl-(alpha 2-6)-D-glucosamine-4-phosphate analogues of lipid A.
Shimizu C; Ikeda K; Achiwa K
Chem Pharm Bull (Tokyo); 1988 May; 36(5):1772-8. PubMed ID: 3203416
[No Abstract] [Full Text] [Related]
17. Relationship of structure and biological activity of monosaccharide lipid A analogues to induction of nitric oxide production by murine macrophage RAW264.7 cells.
Funatogawa K; Matsuura M; Nakano M; Kiso M; Hasegawa A
Infect Immun; 1998 Dec; 66(12):5792-8. PubMed ID: 9826356
[TBL] [Abstract][Full Text] [Related]
18. Biological activities of chemically synthesized N-acylated serine-linked lipid A analog in mice.
Shimizu T; Sugiyama K; Iwamoto Y; Yanagihara Y; Asahara T; Ikeda K; Achiwa K
Int J Immunopharmacol; 1994 Aug; 16(8):659-65. PubMed ID: 7989134
[TBL] [Abstract][Full Text] [Related]
19. Biological activities of analogues of lipid A based chemically on the revised structural model. Comparison of mediator-inducing, immunomodulating and endotoxic activities.
Kanegasaki S; Kojima Y; Matsuura M; Homma JY; Yamamoto A; Kumazawa Y; Tanamoto K; Yasuda T; Tsumita T; Imoto M
Eur J Biochem; 1984 Sep; 143(2):237-42. PubMed ID: 6468393
[TBL] [Abstract][Full Text] [Related]
20. Biological activities of chemically synthesized partial structure analogues of lipid A.
Matsuura M; Yamamoto A; Kojima Y; Homma JY; Kiso M; Hasegawa A
J Biochem; 1985 Nov; 98(5):1229-37. PubMed ID: 4086478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
